awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38550459-239E3D5B-93B1-4194-91A5-15C047416811
Q38550459-239E3D5B-93B1-4194-91A5-15C047416811
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38550459-239E3D5B-93B1-4194-91A5-15C047416811
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives.
P2860
Q38550459-239E3D5B-93B1-4194-91A5-15C047416811
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38550459-239E3D5B-93B1-4194-91A5-15C047416811
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
322ab9d82bcb68582a7bfacfa1238668b22b667c
P2860
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.